Regarding “Dacron carotid patch infection: A report of eight cases”  by Sternbergh, W.Charles
region is surgical decompression of the thoracic outlet before or
immediately after stent placement. One situation in which this
can be done is the Paget-Schroetter syndrome or effort throm-
bosis, after successful thrombolytic therapy.
However, I would like to underline that in our two cases
external compression of the stents occurred not in the subclavian
vein but in the innominate vein. This venous segment is intratho-
racic and usually considered to be safe for stenting. The stents
placed were short (4 cm for the Nitinol Sinus-Stent, probably ≤
4.5 cm for the Palmaz stent due to slight over dilatation) and
located beyond the subclavian-jugular confluence. We therefore
believe that in this situation surgical decompression of the tho-
racic outlet would have been ineffective. The mechanism of exter-
nal compression in this region is different from a subclavian
compression, and does not result from arm movements or
impingement between the first rib and clavicle, but from com-
pression between the manubrium and aortic arch. The phlebo-
graphic studies from Tanaka et al,1 performed during respiratory
movements, support this hypothesis.
I agree with Pr. Molina that stent placement is a “no-return
maneuver.” Surgery of the left brachiocephalic vein is very aggres-
sive and technically challenging (midsternal incision), usually
requiring a bypass from the left internal jugular vein to the right
atrial appendage. In addition, results are jeopardized by graft
stenosis or thrombosis. We would therefore suggest, as we did in
our conclusion, to consider conservative treatment first (with AV
fistula closure), since congestive symptoms will usually resolve
progressively with the development of collateral veins.
Frank D. Hammer, MD
Department of Radiology and Medical Imaging
University Hospital St Luc
Brussels, Belgium
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Regarding “Dacron carotid patch infection: a report
of eight cases”
To the Editors:
I read with interest the recent article by Dr Rizzo and col-
leagues (J Vasc Surg 2000;32:602-6) on management of Dacron
carotid patch infections. Three patients presented late (236, 750,
1060 days after endarterectomy), while five patients presented more
acutely (mean, 28.6 days; range, 13-43). The late infections were all
managed with patch excision and interposition vein grafts, while the
early infections were treated with replacement of the Dacron patch
with a vein patch. These procedures were clearly difficult, even in
the hands of the experienced surgeons at the Cleveland Clinic1;
there was a 25% (2/8) incidence of cranial nerve injury and 12.5%
(1/8) risk of myocardial infarction and stroke. In light of this sub-
stantial morbidity, are there other treatment options?
In those patients presenting late (> 6 months), some with
pseudoaneurysms, no other treatment strategy seems reasonable.
However, in patients presenting more acutely after endarterec-
tomy, operative drainage of the infection with preservation of the
Dacron patch may be an option. In a personal series of 201 con-
secutive carotid endarterectomies (CEAs) performed between
August 1996 and August 2000, 80% (161) were closed with a
Dacron patch, 0.5% (1) closed with a vein patch, 14.9% (30)
closed primarily, and 4.5% (9) underwent internal carotid artery
(ICA) shortening with use of redundant ICA as an autogenous
patch. In this series, two patients closed with a Dacron patch
(1.2% [2/161]) and presented with early infection, similar to the
1.8% reported by Rizzo et al. No late infections have occurred.
Patient 1: A 69-year-old male without diabetes mellitus under-
went CEA with Dacron closure October 1996. The operation
was fairly difficult, with plaque extending well past the
hypoglossal nerve, requiring division of the occipital artery and
posterior digastric muscle in order to obtain distal control. He
presented 12 days later with local neck erythema, tenderness,
and swelling. A duplex ultrasound revealed no pseudoaneurysm
or residual stenosis. He was taken to the operating room with
plans to replace the Dacron patch with saphenous vein. Gross
purulence was found deep to the platysma. Cultures grew alpha-
hemolytic streptococcus. The distal ICA dissection was very
treacherous because of severe inflammation and the previous
high exposure; adequate distal exposure could not be safely
obtained. Thus, after copious irrigation, the sternocleidomastoid
muscle was tacked over the patch, and the platysma, subcuta-
neous tissues, and skin were left open. This wound healed
within 1 month, and at 46 months of follow-up, he has had no
evidence of further infection.
Patient 2: A 52-year-old female with diabetes mellitus under-
went CEA with Dacron patch closure September 1999 and pre-
sented 17 days later with neck swelling, tenderness, and
erythema. Duplex ultrasound revealed no pseudoaneurysm. At
surgery, gross purulence deep to the platysma was confirmed.
Cultures grew alpha-hemolytic streptococcus. After thorough
irrigation, the sternocleidomastoid was tacked over the
endarterectomy site with the remainder of the incision left open.
With routine wound care, complete healing was observed in 2
weeks. At 11 months’ follow-up, the patient shows no evidence
of recurrent infection.
Both of these patients presented early with infection from a
pan-sensitive skin fluora. Successful preservation of the Dacron
patch was obtained with aggressive drainage and irrigation,
sternocleidomastoid myoplasty, and routine wound care to the
opened incision. No cranial nerve injuries, strokes, or other mor-
bidity occurred.
Removal of all foreign material from an infected wound is sur-
gical dogma; many would consider it heresy not to do so in a con-
taminated vascular wound. However, selective nonexcisional
treatment of infected wounds containing vascular prosthetic
patches has been successful in other vascular beds,2 including the
carotid position.3 The fairly indolent nature of the alpha strep
encountered in these two patients may also have contributed to a
successful outcome. While no firm treatment recommendations
can be espoused on the basis of a few patients, it seems reasonable
to suggest that simple drainage should not be applied to carotid
patch infections presenting late; one patient in the series from
Rizzo et al had this performed at an outside facility and then pre-
sented with patch disruption and hemorrhage. However, in
patients presenting early after CEA (< 4-6 weeks) who do not have
a pseudoaneurysm, aggressive surgical drainage, myoplasty, and
wound care have been successful anecdotally. Importantly, the sig-
nificant morbidity associated with early reoperative carotid surgery
in an infected field, as documented by Rizzo et al, is avoided.
The reporting of these two cases should suggest neither
unbridled enthusiasm for nor confidence in the therapy employed.
Treatment decisions must be individualized. Unfortunately, there
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is a relative dearth of data in the literature with which to guide
therapy. A multicenter review of this uncommon problem is
needed to better clarify the potential risks and benefits of various
treatment options.
W. Charles Sternbergh III, MD
Ochsner Clinic
New Orleans, La
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Reply
We appreciate Dr Sternbergh’s response to our article and
the interesting perspective provided by his experience with two
additional patients, both of whom developed deep cervical infec-
tions caused by alpha-hemolytic streptococcus within 3 weeks
after carotid endarterectomy but were successfully treated by
antibiotics and local wound measures without excision of their
Dacron patches. Provided a satisfactory greater saphenous vein
had been present in either groin, we probably would have
replaced each of these patches with a vein patch simply because of
the traditional concern that antibiotics, debridement, and even
muscular coverage may not be sufficient to overcome bacterial
contamination in a fabric arterial prosthesis. While we agree that
early reoperations can be difficult, most of the morbidity in our
series that was mentioned by Dr Sternbergh—the two cranial
nerve injuries and a stroke related to preoperative angiography—
actually occurred in patients who presented with late patch infec-
tions and required reconstruction with vein grafts.
The surgical approach that was taken for the two early postop-
erative infections described by Dr Sternbergh brings to mind the
strategy that was introduced several years ago by Bandyk et al1 for
the management of late femoral graft biofilm infections caused by
Staphylococcus epidermidis, another organism that generally has low
clinical virulence. This strategy also emphasizes adequate debride-
ment and coverage with viable muscle—in this case, the sartorius—
but one of its important principles is replacement of all infected
Dacron with nonporous polytetrafluorethylene (PTFE) in order to
avoid persistent bacterial colonization in the interstices of a fabric
graft. (It seems safe to say that an autogenous replacement graft
would be just as appropriate as PTFE, or even more so, if one hav-
ing an adequate diameter were available.) As Dr Sternbergh is the
first to point out, the fact that this principle was not followed in
either of his patients does not invalidate it. He made a value judg-
ment based on the conditions as he found them, and it appears to
have been correct. However, he undoubtedly followed both of
these patients very closely and was prepared to excise their Dacron
patches if there had been any evidence of lingering infection.
Norman R. Hertzer, MD
Department of Vascular Surgery
The Cleveland Clinic Foundation
Cleveland, Ohio
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Regarding “Management of leg ulcers in patients
with rheumatoid arthritis or systemic sclerosis: the
importance of concomitant arterial and venous
disease”
To the Editors:
In their recent paper, Hafner et al1 are to be commended for
their thorough vascular assessment of patients with rheumatolog-
ical disease who have a leg ulcer. Like ourselves,2 they found that
leg ulcers in RA often have a multifactorial etiology with little
clinical evidence of vasculitis. It is important to stress, however,
that serological evidence of systemic vasculitis such as hypocom-
plementemia or positive tests for antineutrophil cytoplasmic anti-
bodies are usually lacking in systemic rheumatoid vasculitis and
cannot be used to exclude this diagnosis. Clinical clues such as
nail-fold infarcts, pericarditis, mononeuritis multiplex, or marked
constitutional symptoms should be looked for. If found, patients
should be referred to a rheumatologist for consideration of
immunosuppressive therapy. The absence of these features, how-
ever, should prompt an assessment of large vessel function such as
the authors describe. We also have anecdotal evidence of appro-
priate vascular intervention leading to ulcer healing in RA and
support their call for a formal study of the effectiveness of surgi-
cal intervention in these patients when evidence of systemic vas-
culitis is absent.
Euan McRorie, MD, FRCP(Edin)
Rheumatic Diseases Unit
Western General Hospital
Edinburgh, UK
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Reply
We acknowledge Dr McRorie’s valuable comments in
response to our publication on leg ulcers in patients with rheuma-
toid arthritis or systemic sclerosis. Obviously, we agree that
patients with clinical signs of systemic vasculitis should be referred
to a rheumatologist for further assessment and, where appropri-
ate, for immunosuppressive therapy. Among the nine patients
with rheumatoid arthritis and leg ulcers presented in our paper,
none had signs of nail-fold infarcts, pericarditis, mononeuritis
multiplex, renal involvement, or other symptoms of systemic vas-
culitis. Several among them (4/9) received additional immuno-
suppressive therapy for their ulcers, without improvement. It was
remarkable that some of the patients (5/9) had never been sub-
jected to vascular assessment. Often the initial cause for leg ulcer-
ation in rheumatoid arthritis remains unclear and must be left to
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